Xtl Biopharmaceuticals Ltd (XTLB) SEC Filings — 2024
13 SEC filings for Xtl Biopharmaceuticals Ltd (XTLB) in 2024.
Filings
- XTL Biopharma Reports H1 2024 Results, Solar Project Term Sheet — 6-K · Dec 30, 2024
- XTL Biopharma Settles with Social Proxy CEO & Shareholders — 6-K · Nov 19, 2024
- XTL Biopharma Settles Social Proxy Acquisition Claims — 6-K · Nov 12, 2024
- XTL Biopharma Faces Controversy with AI Subsidiary — 6-K · Oct 15, 2024
- XTL Biopharmaceuticals Acquires AI Data Firm Social Proxy — 6-K · Aug 14, 2024
- XTL Biopharma Announces Meeting Results — 6-K · Jul 22, 2024
- XTL Biopharma Sets Shareholder Meeting for July 22 — 6-K · Jun 12, 2024
- XTL Biopharmaceuticals to Acquire AI Data Company Social Proxy — 6-K · Jun 5, 2024
- XTL Biopharma Reports Q1 2024 Results, Seeks Strategic Partner — 6-K · May 13, 2024
- XTL Biopharmaceuticals Ltd. Files Annual Report on Form 20-F for Fiscal Year Ended December 31, 2023 — 20-F · Apr 30, 2024
- XTL Biopharma Regains Nasdaq Minimum Bid Price Compliance — 6-K · Apr 2, 2024
- XTL Biopharma Schedules Shareholder Meeting for April 30 — 6-K · Mar 21, 2024
- XTL Biopharma to Acquire AI Web Data Firm Social Proxy — 6-K · Mar 20, 2024